Answers are grounded in this paper and cite their sources.
Quantifying early changes in heterogeneity through a dedicated radiomics score could improve response evaluation for patients with DT undergoing chemotherapy.
No takes yet. Share an insight, caveat, or question.
Crombé et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: